QUADRI MENINGO VACCINE
Get Price Quote
MENINGOCOCCAL POLYSACCHARIDE VACCINE (Group A, C, Y & W135) I.P. Quadri MeningoTM Polysaccharide vaccine against cerebrospinal meningitis caused by Neisseria meningitides Group A, C, Y &W135. Quadri MeningoTM fulfils the specification of Meningococcal Polysaccharide Vaccine as given in Indian Pharmacopoeia. The manufacturing facilities meets the requirements of cGMP guidelines of revised schedule ‘M’ of Government of India. INDICATIONS Prevention of cerebrospinal meningitis caused by Neisseria meningitides Group A, C, Y & W135. Vaccination is recommended in regions of endemic infection, travellers to countries with epidemic meningococcal disease (Haji pilgrims), household or institutional contacts, military recruits. It is also recommended for subjects living in closed communities and close contact of patients/carriers of Meningococcal Group A, C, Y & W135. COMPOSITION Each dose (0.5 ml) of vaccine contains: Purified Polysaccharide of Neisseria meningitidis -Group A……………………………………………………………………………………………50 µg -Group C……………………………………………………………………………………………50 µg -Group Y……………………………………………………………………………………………50 µg -Group W135………………..……………………………..……………………………………50 µg Lactose I.P. (Stabilizer) ………………………….……………………………….…5 mg Thimerosal I.P. (Preservative) ……….………………………………………….……0.05 mg PACK SIZE One, five and ten dose in glass vial with appropriate diluents.
Meningococcal Vaccine
Get Price Quote
Meningococcal Vaccine, Haemophilus Influenzae Vaccine
Best Deals from Meningococcal Vaccine